BWL
ZVRA icon

Bogart Wealth LLC’s Zevra Therapeutics ZVRA Stock Holding History

Bogart Wealth LLC’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301 Hold
21
– – ﹤0.01% 1871
2026
Q1 		$196 Buy
+21
New +$189 ﹤0.01% 1700
2025
Q4 		– Sell
-300
Closed -$2.85K – 1689
2025
Q3 		$2.85K Buy
+300
New +$3.01K ﹤0.01% 1082

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bogart Wealth LLC's ZVRA Position: Q2 2026 in Review

Bogart Wealth LLC held its Zevra Therapeutics (ZVRA) position steady in Q2 2026 at 21 shares worth $301. The position accounts for ﹤0.01% of the portfolio, ranked #1871.

Bogart Wealth LLC first reported a position in ZVRA in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.85K in Q3 2025. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Bogart Wealth LLC held 21 shares of Zevra Therapeutics worth $301 as of Q2 2026.
  • Bogart Wealth LLC left its Zevra Therapeutics share count unchanged in Q2 2026.
  • Zevra Therapeutics made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1871 holding.
  • Bogart Wealth LLC first reported a position in Zevra Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Bogart Wealth LLC's Zevra Therapeutics position peaked at $2.85K in Q3 2025.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.